The hemostat market is projected to experience robust growth over the next decade, with the market expected to grow from a valuation of USD 78.70 million in 2022 to reach an estimated USD 134.43 ...

United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's regulatory and capital markets activities. As previously disclosed, the FDA requested that certain additional ...

Chandigarh [India], February 28: SeraSeal™, the world's first and only primary hemostatic agent, has been approved for use in ...